Description
Baricitinib is indicated for the treatment of moderate to severely active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs. Baricitinib may be used as monotherapy or in combination with methotrexate.
Reviews
There are no reviews yet.